Endokarditli Hastada Sezaryen Anestezisi

Authors

Başak Pehlivan

Synopsis

Infective endocarditis (IE) is an important infectious disease with high morbidity and mortality that develops on the endocardial surface. While its incidence in developed countries is approximately 6/100,000, the in-hospital mortality rate in Turkey is around 25-30%. Prominent causative microorganisms include Staphylococcus aureus, streptococci, coagulase-negative staphylococci, enterococci, and Brucella spp. in Turkey. Vegetation matures on mechanically damaged endocardium through the formation of non-bacterial thrombotic endocarditis and bacterial colonization following bacteremia. Diagnosis cannot be established by a single test and is made according to ESC major and minor criteria using clinical findings, blood cultures, and imaging techniques, with echocardiography being the first choice. Synergistic antibiotic combinations are administered for at least 4-6 weeks in treatment. Although rare during pregnancy, IE is a critical condition with a maternal mortality of 11% and a fetal mortality of 16%. Its management should be planned by a multidisciplinary team consisting of specialists in obstetrics, cardiology, cardiovascular surgery, and neonatology. In the anesthetic approach for Cesarean section operations, agents such as ketorolac, acetaminophen, and lidocaine can be preferred preoperatively to reduce hemodynamic stress and pain. Intraoperatively, ECG, capnography, intra-arterial, and central venous pressure monitoring should be performed, and rapid sequence intubation should be applied with lidocaine, propofol, and a muscle relaxant. After the delivery of the baby and clamping of the umbilical cord, fentanyl and oxytocin are administered, anesthesia maintenance is continued with an inhalation anesthetic, and the patient is extubated in a manner that will not cause abrupt hemodynamic changes.

References

Bin Abdulhak AA, Baddour LM, Erwin PJ, et al. Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. Glob Heart. 2014; 9(1): 131-43.

Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021): 882-93.

Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15): 1435-86.

Şimşek-Yavuz S, Şensoy A, Kaşıkçıoğlu H, et al. Infective endocarditis in Turkey: aetiology, clinical features, and analysis of risk factors for mortality in 325 cases. Int J Infect Dis. 2015; 30: 106-14.

Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013; 368(15): 1425-33.

Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol.2011; 3: 67-84.

Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart. 2008; 94(12): 1534-40.

Allegranzi B, Nejad SB, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011; 377(9761): 228-41.

Fowler VG, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis a consequence of medical progress. JAMA. 2005; 293(24): 3012-21.

Ambrosioni J, Hernandez-Meneses M, Tellez A, et al. The changing epidemiology of infective endocarditis in the twenty-first century. Curr Infect Dis Rep. 2017; 19(5): 21.

Holland TL, Baddour LM, Bayer AS, et al. Infective endocarditis. Nat Rev Dis Primers. 2016; 2: 16059.

Werdan K, Dietz S, Loffler B, et al. Mechanisms of infective endocarditis: pathogen-host interaction and risk states. Nat Rev Cardiol. 2014; 11(1): 35-50.

Fowler VG, Scheld WM, Bayer AS. Endocarditis and intravascular infections. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, PA: Elsevier Saunders, 2015: 990- 1028.

Yang E, Frazee BW. Infective endocarditis. Emerg Med Clin North Am. 2018; 36(4): 645-63

Thuny F, Grisoli D, Collart F, et al. Management of infective endocarditis: challenges and perspectives. Lancet. 2012; 379(9819): 965-75

Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. Arch Intern Med. 2009; 169(5): 463-73.

Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000 30(4): 633-8.

Cornelissen CG, Frechen D, Schreiner K, et al. Inflammatory parameters and prediction of prognosis in infective endocarditis. BMC Infect Dis 2013; 13(272).

Kahveci G, Bayrak F, Mutlu B, et al. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis. Am J Cardiol. 2007; 99(10): 1429-33.

Şimşek-Yavuz S. İnfektif endokardit: güncel bilgiler. Klimik Derg. 2015; 28(2): 46-67.

Pazin GJ SS, Thompson ME. Blood culture positivity: suppression by outpatient antibi otic therapy in patients with bacterialendocarditis. Arch Intern Med. 1982; 142(2): 263-8

Authors/Task Force Members, Habib G, Lancellotti P, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075–128

Yuan SM. Infective endocarditis during pregnancy. J Coll Physicians Surg Pak. 2015; 25(2): 134-9.

Kebed KY, Bishu K, Al Adham RI, et al. Pregnancy and postpartum infective endocarditis: a systematic review. Mayo Clin Proc. 2014; 89(8): 1143-52.

Vizzardi E, De Cicco G, Zanini G, et al. Infectious endocarditis during pregnancy, problems in the decision-making process: a case report. Cases J. 2009; 2: 6537

Connolly C, O’Donoghue K, Doran H, et al. Infective endocarditis in pregnancy: case report and review of the literature. Obstet Med. 2015; 8(2): 102-4

Barth WH. Cardiac surgery in pregnancy. Clin Obstet Gynecol. 2009; 52(4): 630-46.

Eliopoulos GM. Principles of anti-infective therapy. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, PA: Elsevier Saunders; 2015: 224-34.

Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford Guide To Antimicrobial Therapy. 43rd ed. USA: Antimicrobial Therapy, Inc.; 2013; 30.

M R El-Tahan, O M Warda, A M Yasseen, et al. Preoperative ketorolac-acetaminophen-lidocaine with isoflurane-propofol anaesthesia for Caesarean section in a patient with infective endocarditis Br J Anaesth 2008 Oct;101(4):578-9.

El-Tahan MR, Warda OM, Yasseen AM, et al. A randomized study of the effects of preoperative ketorolac on general anaesthesia for caesarean section. Int J Obstet Anesth 2007;16: 214–20

Wang et al. Diagnosis and treatment of infective endocarditis in pregnancy: a case report Journal of Cardiothoracic Surgery 2020 15:109

Pages

199-206

Published

November 17, 2021

License

License